The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of hypertension (HTN) on progression-free survival (PFS) in patients (pts) receiving front-line bevacizumab (BEV) for primary advanced ovarian cancer (OC) in the NOGGO single-arm OTILIA study: A post hoc analysis in 808 pts.
 
Robert Armbrust
No Relationships to Disclose
 
Pauline Wimberger
Honoraria - Amgen; AstraZeneca; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Celgene; MSD; Novartis; Pfizer; PharmaMar; Roche
 
Alexander Mustea
Honoraria - Roche
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Roche; Tesaro
 
Gülten Oskay-Özcelik
Honoraria - Amgen; AstraZeneca; Novartis; Roche
Consulting or Advisory Role - AstraZeneca; Novartis; Roche
Travel, Accommodations, Expenses - Roche
 
Maren Keller
No Relationships to Disclose
 
Rolf Richter
No Relationships to Disclose
 
Johanna Harde
No Relationships to Disclose
 
Max Zortel
Employment - Roche Pharma AG
 
Andrea Wegenaer
Employment - Roche Pharma AG
Stock and Other Ownership Interests - Roche Pharma AG
 
Oliver Tome
No Relationships to Disclose
 
Jalid Sehouli
Honoraria - AstraZeneca; Roche
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Novartis; Roche; Tesaro
Research Funding - Amgen; Bayer; Lilly; Novartis